-
"It was incredibly disappointing, " laments retired SmithKline executive Martin Rosenberg, who led the effort.
FORBES: On The Cover/Top Stories
-
"This vaccine will have a huge impact, " predicts Jean Stephenne, chief of Glaxo- Smithkline's vaccine unit.
FORBES: Magazine Article
-
SmithKline Beecham's chief scientific officer, George Poste, speaks of pharmacogenomics as the savior of the industry.
FORBES: Tailor-made drugs